pubrio
LaNova Medicines

LaNova Medicines

China · Biotechnology

Biotechnology

Founded in 2019 in Shanghai, China, LaNova Medicines is a clinical-stage biotechnology company committed to the discovery and development of novel biologic drugs for cancer treatment. Led by industry veterans with a strong passion for innovation, we aim to operate as an R&D engine and deliver transformative medicines to address the unmet clinical needs of cancer patients. Leveraging our proprietary technology platforms and deep understanding of the tumor microenvironment. we have built a differentiated pipeline of products and are striving to progress our programs toward the clinic.

Company Insights
Company Overview

2019

Founded

Biotechnology

Industry

China

Location

10,936,730

Ranking

15 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding LaNova Medicines

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​